Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A tiny chest patch could tell doctors who's ready to leave the hospital

NCT ID NCT05181111

Disease control Sponsor: Rijnstate Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether continuously monitoring patients in the acute admission ward with a small chest-worn sensor can help doctors decide who is safe to go home. The sensor tracks heart rate, breathing, posture, and activity. Researchers will compare outcomes like discharge rates, hospital stay length, and ICU admissions between patients monitored with the sensor and those receiving usual care. The goal is to see if this technology can make triage and discharge decisions faster and more accurate.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A wearable sensor (Philips Healthdot) that tracks vital signs like heart rate and breathing, plus posture and activity levels.
What this could lead to
If it works, continuous monitoring could help hospitals send patients home sooner and spot problems earlier, improving care and reducing strain on hospital beds.
What could go wrong
This is a single-hospital study, and the sensor may not always be accurate or comfortable. It's unclear if the benefits will be large enough to change routine practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

400 people

The number who actually took part.

Started

Dec 2021

Finished

Nov 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: In order for a patient to be eligible to participate in this study, the following criteria need to be met: * admitted to the AAW * Age ≥ 18 years * Able to speak and read Dutch * Willing and able to provide written informed consent Exclusion Criteria: A patient who meets any of the following criteria will be excluded from participation: * Not able or willing to wear a wearable sensor on the chest continuously for 14 days * Planned major surgery in the upcoming 30 days * At the time of AAW admission already known to be discharged home or admitted to the hospital * Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed * Known sensitivity to medical adhesives * Wearing an active implantable device (e.g. ICD, pacemaker) * Intend to go to the sauna or go swimming in the upcoming 14 days * Pregnant or breastfeeding * Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute disease Clinical Deterioration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute disease Clinical deterioration Monitoring

Contacts and locations

Locations

  • Rijnstate Hospital

    Arnhem, 6800 TA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.